title: Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours.
abstract: Expression of pS2 was studied by immunocytochemistry in normal breast tissue (n = 20), benign tumours (n = 9) and 145 breast cancers representative of the different histological types. pS2 immunostaining was scored as negative (D1 = 0-5% stained cells), positive (D2 = 5-75% stained cells) or highly positive (D3 > 75% stained cells). pS2 protein was evident in all normal breast samples examined. Six of nine benign lesions showed pS2 staining. In both cases, immunostaining was weaker than in breast cancers. Of breast cancers, 77/145 (53.1%) were pS2 positive, including 33.1% with intense staining. The presence of pS2 was not correlated with the age of patients, the size of the primary tumour, or lymph node status, but was correlated with histological grading and nuclear grading. pS2 expression was also correlated with menopausal status and oestrogen receptor status (59% of receptor-positive tumours were pS2 positive), but not to progesterone receptor status. pS2 expression in breast carcinomas is not a characteristic of specific histological types. Although this protein is predominantly expressed in oestrogen receptor-positive and differentiated tumours, it shows oestrogen-independent expression in about 30% of cases.
authors.affiliation: Centre René Huguenin de Lutte Contre le Cancer, Saint-Cloud, France.
authors.forename: C
authors.initials: C
authors.lastname: Pallud
authors.forename: V
authors.initials: V
authors.lastname: Le Doussal
authors.forename: M F
authors.initials: MF
authors.lastname: Pichon
authors.forename: J F
authors.initials: JF
authors.lastname: Prud'homme
authors.forename: K
authors.initials: K
authors.lastname: Hacene
authors.forename: E
authors.initials: E
authors.lastname: Milgrom
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D001940:Breast / Q000737:chemistry*; D001941:Breast Diseases / Q000378:metabolism; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis*; D011506:Proteins; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D011506:Proteins; C051838:TFF1 protein, human; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins